Endocrinology

Review: Management of Hypopituitarism

15 Jan, 2020 | 01:04h | UTC

Guideline Homepage: ADA 2020 Standards of Medical Care in Diabetes – American Diabetes Association (free supplement)

Commentaries: ADA 2020 Standards of Care Incorporate CVD Risk Stratification, New Medications – Endocrinology Advisor (free) AND ADA releases 2020 standards of medical care in diabetes – University of North Carolina at Chapel Hill School of Medicine (free)

See also: Standards of Medical Care in Diabetes—2020 Abridged for Primary Care Providers – American Diabetes Association (free PDF) AND 2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) – Diabetologia (free)

 

See ADA 2020 Guideline topics below:

Introduction: Standards of Medical Care in Diabetes—2020

Summary of Revisions: Standards of Medical Care in Diabetes—2020

  1. Improving Care and Promoting Health in Populations: Standards of Medical Care in Diabetes2020
  2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2020
  3. Prevention or Delay of Type 2 Diabetes: Standards of Medical Care in Diabetes—2020
  4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes—2020
  5. Facilitating Behavior Change and Well-being to Improve Health Outcomes: Standards of Medical Care in Diabetes—2020
  6. Glycemic Targets: Standards of Medical Care in Diabetes—2020
  7. Diabetes Technology: Standards of Medical Care in Diabetes—2020
  8. Obesity Management for the Treatment of Type 2 Diabetes: Standards of Medical Care in Diabetes—2020
  9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2020
  10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2020
  11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes−2020
  12. Older Adults: Standards of Medical Care in Diabetes—2020
  13. Children and Adolescents: Standards of Medical Care in Diabetes−2020
  14. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes—2020
  15. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes—2020

 

Related Commentary on Twitter

 


NICE Guideline: Menopause

6 Dec, 2019 | 10:50h | UTC

Global Atlas on Childhood Obesity

7 Oct, 2019 | 06:01h | UTC

Medications Affecting the Biochemical Conversion to Type 2 Diabetes: A Systematic Review and Meta-Analysis – The Journal of Clinical Endocrinology & Metabolism (free)

α-Glucosidase inhibitors, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, metformin, orlistat, phentermine/topiramate, and pioglitazone significantly reduced the risk of biochemical conversion to T2DM, whereas statins and nateglinide increased the risk”

 


Review: Diabetes and Bone

23 May, 2019 | 13:13h | UTC

Recent advances in diabetes treatments and their perioperative implications – Current Opinion in Anesthesiology (free)

Source: Critical Care Reviews Newsletter

“Sulfonylureas and SGLT2i should be ceased before moderate or major surgery. Other oral antihyperglycemic therapies may be continued or ceased.

 


Efficacy of population‐wide diabetes and obesity prevention programs: An overview of systematic reviews on proximal, intermediate, and distal outcomes and a meta‐analysis of impact on BMI – Obesity Reviews (free)

 

Related Commentary on Twitter

 


Clinical Management of Intermittent Fasting in Patients with Diabetes Mellitus – Nutrients (free)

The authors acknowledge the almost non-existent evidence on this issue and suggest practical recommendations for the care of these patients.

 


Latest Updates on Lipid Management

21 Apr, 2019 | 21:14h | UTC

Thyrotoxicosis: Diagnosis and Management

26 Mar, 2019 | 01:43h | UTC

Review: Glucose Control in the ICU

6 Mar, 2019 | 01:27h | UTC

Incidence of sight‐threatening diabetic retinopathy in people with Type 2 diabetes mellitus and numbers needed to screen: a systematic review – Diabetic Medicine (free PDF)

Commentary: How often should patients with T2D be screened for retinopathy? – Univadis (free registration required)

Related: Evidence‐based Guidelines for Screening of Diabetic Retinopathy (free)

“This review supports lengthening of the screening interval of patients with Type 2 diabetes without retinopathy at last screening session”

 


Worldwide Dyslipidemia Guidelines

4 Feb, 2019 | 22:32h | UTC

Evidence‐based Danish guidelines for screening of diabetic retinopathy – Acta Ophthalmologica (free)

“There is solid evidence to support a flexible, individualized screening regimen. In particular, it is possible to prolong screening intervals to 24–48 months for patients with no or mild nonproliferative diabetic retinopathy”.

 


Just Out! Guideline: ADA 2020 Standards of Medical Care in Diabetes (free guideline and topics)

 

ADA 2019 Standards of Medical Care in Diabetes (free supplement)

News Release: Patient-centered Care is the Focus and Priority of the 2019 Standards of Medical Care in Diabetes, Published Today by the American Diabetes Association (free)

Summary of Revisions: Standards of Medical Care in Diabetes—2019 (free)

See also: Standards of Medical Care in Diabetes—2019 Abridged for Primary Care Providers (free PDF)

 

Related Commentary on Twitter


Page 1 of 11

Join our WhatsApp group

Free Updates in All Specialties!

A daily update on the latest medical news, practice-changing trials and guidelines

Stay Updated in Your Specialty
No spam, just news
Unsubscribe with one click

 

Daily

 

Weekly or Less Often 
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •